Laser Iridotomy Versus Phacoemulsification in Acute Angle Closure
Angle Closure Glaucoma
About this trial
This is an interventional treatment trial for Angle Closure Glaucoma focused on measuring Acute primary angle closure, Laser preipheral iridotomy, Phacoemulsification
Eligibility Criteria
Inclusion Criteria: APACG. In cases where both eyes are eligible, the right eye will be entered. IOP less than or equal to 30 mmHg within 24 hours of presentation and after initiation of medical treatment Significant cataract with best corrected visual acuity equal or less than 6/15 Informed consent Exclusion Criteria: Secondary causes of angle-closure e.g. subluxed lens, uveitis, trauma and neovascular glaucoma Intumescent cataract (phacomorphic glaucoma) Eyes with anterior chamber depth differing by more than 0.3 mm Eyes with no cataract Active ocular infection in either eye which would prevent surgery Female subjects who are pregnant, nursing or of childbearing potential and not using adequate contraception Participating in another study Previous intraocular eye surgery on the affected eye. Any medical condition which would be a contra-indication to surgery
Sites / Locations
- Singapore National Eye Centre